Experience

Valneva Announces up to $500 Million Debt Facility With Pharmakon Advisors

October 6, 2025

Cooley advised Valneva, a specialty vaccine company that develops, manufactures and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs, on a debt facility for up to $500 million in nondilutive financing with funds managed by Pharmakon Advisors.

Read more

Related contacts

Mischi a Marca
Partner, San Francisco
Shimeng Cheng
Special Counsel, San Francisco
Katie Kazem
Partner, Reston
Amanda Fant
Associate, New York
Kavi Huded
Associate, New York
Marc Recht
Partner, Boston
Dr. Jon Cousin
Partner, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Christophe Beauduin
Partner, New York
Rena Kaminsky
Special Counsel, Palo Alto
Xander Lee
Partner, Santa Monica
Michael Bergmann
Partner, Washington, DC
Kathleen Goodhart
Partner, San Francisco
Lyndsey M. Kruzer
Partner, Boston
Phil Mitchell
Partner, New York
Francis Wheeler
Senior Counsel, Colorado
Amy Hallman Rice
Special Counsel, San Diego
Karen Tsai
Special Counsel, Washington, DC
Shehzad Akram
Associate, London
Trevor Bossi
Associate, Boston
Jameson Davis
Associate, Boston
Melanie Simon-Giblin
Associate, New York
Chris Rhem
Paralegal Specialist, San Francisco

Related Practices & Industries

AttackIQ Acquires Assets from DeepSurface

February 4, 2025

Cooley advised AttackIQ, a leading vendor of adversarial exposure validation solutions, on its acquisition of assets from DeepSurface Security, a security posture management and vulnerability prioritization company. Partner Matt Browne led the Cooley team advising AttackIQ.

Related contacts

Matt Browne
Partner, San Diego
Amy Hallman Rice
Special Counsel, San Diego
Michael Pelle
Associate, New York
Eileen Marshall
Partner, Washington, DC
David Walsh
Senior Counsel, Reston

Related Practices & Industries

Cortica Raises $80 Million in Financing

November 25, 2024

Cooley advised Cortica, a leading provider of advanced neurological therapies for children with autism and other developmental differences, on its $80 million financing round, co-led by Morgan Health and Nexus NeuroTech Ventures.

Related contacts

Matt Browne
Partner, San Diego
Amy Hallman Rice
Special Counsel, San Diego
Galen Pham
Associate, Santa Monica
Han Wang
Associate, Santa Monica
Todd Gluth
Partner, San Diego
Patrick Sharma
Associate, Santa Monica
Jeff Goldman
Special Counsel, Palo Alto
Stacey A. Bradford
Special Counsel, Washington, DC

ProfoundBio Announces $1.8 Billion Acquisition by Genmab

April 3, 2024

Cooley advised ProfoundBio, a clinical-stage biotechnology company developing novel antibody-drug conjugate therapeutics for patients with cancer, on its definitive agreement to be acquired for $1.8 billion in an all-cash transaction by Genmab (NASDAQ: GMAB), a dual-listed, international biotechnology company that creates and develops differentiated antibody therapeutics to fight against cancer and other serious diseases.

Read more

Related contacts

Rama Padmanabhan
Partner, San Diego
Patrick Loofbourrow
Partner, Singapore
Rowook Park
Partner, San Diego
Ruomu Li
Partner, Shanghai
Jenny Ge
Associate, Santa Monica
Ross Eberly
Partner, Santa Monica
Megan Browdie
Partner, Washington, DC
Christopher Kimball
Partner, Washington, DC
Xander Lee
Partner, Santa Monica
Jamie Leigh
Partner, San Francisco
Izzy Lubarsky
Partner, New York
Barbara Mirza
Partner, Santa Monica
Sonia Nath
Partner, Washington, DC
Jean Park
Partner, New York
Stacey A. Bradford
Special Counsel, Washington, DC
Jeff Goldman
Special Counsel, Palo Alto
Amy Hallman Rice
Special Counsel, San Diego
Karen Tsai
Special Counsel, Washington, DC
Bin Wang
Special Counsel, Palo Alto
Julia R. Brinton
Special Counsel, Washington, DC
Megan Drill
Associate, San Diego
Mari Dugas
Associate, Washington, DC
Allison Kutner
Associate, New York
Jiqiang Lin
Associate, New York
Tyler Saavedra-Buckley
Associate, San Francisco
Patrick Sharma
Associate, Santa Monica
Ivy Wang
Associate, Shanghai
Monica Xu
Special Counsel, Shanghai
Freddy Yip
Associate, Hong Kong
Zhijing Yu
Associate, Singapore
Andy Zachrich
Associate, San Francisco
Letian Wei
Legal Consultant, Shanghai

Related Practices & Industries

MannKind Announces up to $200 Million Royalty Purchase Agreement With Sagard Healthcare

January 2, 2024

Cooley advised MannKind, a company focusing on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases, on the sale of a 1% royalty in net sales of Tyvaso DPI (treprostinil) inhalation powder to Sagard Healthcare for up to $200 million.

Read more

Related contacts

Matt Browne
Partner, San Diego
Amy Hallman Rice
Special Counsel, San Diego
Pitrina Gilger
Associate, San Diego
Amanda Pacheco
Associate, Palo Alto
Mischi a Marca
Partner, San Francisco
Matthew S. Scarano
Associate, San Diego
Asa Henin
Partner, San Diego
Michelle Hunt
Associate
Chris Rhem
Paralegal Specialist, San Francisco

Related Practices & Industries

View more

Admissions and credentials

California

Memberships and affiliations

San Diego County Bar Association

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.